Survey Shows Few Adults Recognize Testicular Cancer as Affecting Young Men
By Lori Solomon HealthDay Reporter

FRIDAY, June 27, 2025 -- Only one in 10 U.S. adults correctly identified testicular cancer as most commonly affecting men under age 40, according to a survey released June16 by The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James).
The survey included 1,008 respondents aged ≥18 years. Results showed that only 13 percent of participants correctly identified testicular cancer as most commonly affecting men under age 40. Six in 10 respondents (63 percent) correctly identified that testicular cancer is often curable if caught early, while just over half (54 percent) correctly said that monthly self-checks should be conducted. Younger adults (aged 18 to 29 years) were more likely than all other age groups to incorrectly agree with the statement that testicular cancer symptoms are always painful (18 percent).
"Testicular cancer does not typically come with painful symptoms," Shawn Dason, M.D., from OSUCCC—James, said in a statement. "That’s why routine self-exams are so important to detect any lumps or changes to the testicle. If you feel something out of the ordinary, like a lump or bump, or if the testicle changes in size, call your doctor."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-06-28 06:00
Read more

- Genetic Tests For Autism, Intellectual Disability Not Being Done On Medicaid Kids
- Muscle Ultrasound Can Detect Insulin Resistance
- Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
- CT Colonography Cost-Effective, Clinically Effective for CRC Screening
- Lilly's Oral GLP-1, Orforglipron, Showed Compelling Efficacy and a Safety Profile Consistent with Injectable GLP-1 Medicines, in Complete Phase 3 Results
- Desogestrel for More Than Five Years May Up Risk of Intracranial Meningioma
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions